收费全文 | 28569篇 |
免费 | 2859篇 |
国内免费 | 2083篇 |
耳鼻咽喉 | 215篇 |
儿科学 | 401篇 |
妇产科学 | 343篇 |
基础医学 | 3339篇 |
口腔科学 | 537篇 |
临床医学 | 3741篇 |
内科学 | 4216篇 |
皮肤病学 | 259篇 |
神经病学 | 1393篇 |
特种医学 | 1266篇 |
外国民族医学 | 12篇 |
外科学 | 3280篇 |
综合类 | 4753篇 |
现状与发展 | 6篇 |
一般理论 | 3篇 |
预防医学 | 1836篇 |
眼科学 | 677篇 |
药学 | 3095篇 |
26篇 | |
中国医学 | 1574篇 |
肿瘤学 | 2539篇 |
2024年 | 25篇 |
2023年 | 383篇 |
2022年 | 596篇 |
2021年 | 1173篇 |
2020年 | 1014篇 |
2019年 | 932篇 |
2018年 | 957篇 |
2017年 | 912篇 |
2016年 | 931篇 |
2015年 | 1310篇 |
2014年 | 1598篇 |
2013年 | 1459篇 |
2012年 | 1941篇 |
2011年 | 2328篇 |
2010年 | 1489篇 |
2009年 | 1155篇 |
2008年 | 1499篇 |
2007年 | 1571篇 |
2006年 | 1514篇 |
2005年 | 1476篇 |
2004年 | 1126篇 |
2003年 | 1140篇 |
2002年 | 1014篇 |
2001年 | 861篇 |
2000年 | 794篇 |
1999年 | 744篇 |
1998年 | 427篇 |
1997年 | 492篇 |
1996年 | 325篇 |
1995年 | 295篇 |
1994年 | 232篇 |
1993年 | 189篇 |
1992年 | 227篇 |
1991年 | 212篇 |
1990年 | 183篇 |
1989年 | 167篇 |
1988年 | 139篇 |
1987年 | 137篇 |
1986年 | 118篇 |
1985年 | 76篇 |
1984年 | 50篇 |
1983年 | 29篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 26篇 |
1979年 | 45篇 |
1978年 | 22篇 |
1976年 | 14篇 |
1975年 | 21篇 |
1974年 | 22篇 |
Aim
Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an immune inhibitory receptor which is expressed within most types of hematopoietic cells and negatively regulates immune responses. Recently, we found LAIR-1 expression to be present within tumors of nonhematopoietic lineages. However, the roles of LAIR-1 in hepatocellular carcinoma (HCC) have yet to be examined. The purpose of this study was to investigate the expression of LAIR-1 in HCC tissue and assess its clinical significance at this site.Materials and methods
Expression levels of LAIR-1 within HCC samples collected from 90 patients and compared with that of slides of normal liver tissue collected from 9 non-HCC patients were measured by immunohistochemistry using tissue microarrays. A semiquantitative score was assigned, as was based on staining intensity and percent of positive cells and a Spearman Rank correlation test was used to assess any potential significant correlations between LAIR-1 expression and clinicopathological factors. Overall survival analysis was performed using the Kaplan-Meier and Log Rank statistical test.Results
LAIR-1 expression was detected in cancer tissue and adjacent tumor tissue, but not in normal liver tissue. The percent of LAIR-1-positive expression in cancer tissue of HCC samples was 97.78% (88/90) while that in adjacent tumor tissue was 96.67% (87/90). Significantly greater expression levels of LAIR-1 were obtained from cancer tissue (Mean?±?SD?=?5.722?±?2.145) than that in adjacent tumor tissue (4.141?±?1.486). In addition, LAIR-1 expression was found to be significantly correlated with pathological grade of HCC, T stage, and age. Expression levels of LAIR-1 were related with worse overall survival rates of HCC patients, especially in HCC patients with hepatic cirrhosis.Conclusion
Results of this study show that LAIR-1 is expressed in HCC tissues and that high levels of LAIR-1 expression are associated with the poor cancer differentiation. In addition, overexpression of LAIR-1 was significantly associated with worse overall survival in the patients with HCC. These data suggest that LAIR-1 may be an independent predictor for clinical outcomes in patients with HCC. 相似文献Objective: To analyze the association between serum CRP levels in patients with malignant tumors and their nutritional status.
Method: A total of 3,692 cases were analyzed and the serum CRP levels were determined using an immunometric assay. Nutritional status was assessed by using patient-generated subjective global assessment (PG-SGA). The biochemical evaluation of prealbumin (PA), albumin (ALB), cholesterol (CHOL), and triglycerides (TG) were assayed within 48?h admission to the hospital. The association between serum CRP concentration and the nutritional status, the stage of the tumor and other factors was analyzed by univariate and multivariate logistic regression analysis.
Result: Elevated serum CRP was observed in 47.6% (1,548/3,269) of patients compared with the reference value, and the median CRP concentration was 18.29?mg/l. Patient serum CRP concentrations in the malnourished group (PG-SGA B?+?C) were higher than in the well-nourished (PG-SGA A) patients (P?<?0.05). The serum CRP level was related to the patients' age, gender, tumor stage, and was affected by hepatitis, liver cirrhosis, diabetes, but it has no effect on hypertension. The CRP high patients had lower PA and ALB levels, lower Karnofsky performance status scores, and higher PG-SGA scores (P?<?0.05), and there was no relationship with CHOL and TG levels. Weight loss in the previous 1?mo was seen with CRP positive patients (P?<?0.05).
Conclusion: Almost 50% of malignant tumor patients had elevated serum CRP levels indicating a systemic inflammatory state. The nutritional status was worse in cancer patients with higher concentrations of serum CRP. The level of CRP was associated with the tumor stage, and, as stage is a prognostic factor, so can CRP be used as a prognostic maker in malignant tumors patients. 相似文献
Oxidant toxicity has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), an insidiously progressive neurodegenerative disorder involving upper and lower motor neurons. Here, we investigated the cellular and molecular mechanisms underlying the neuroprotective effects of an anti-oxidant genistein in SOD1-G93A transgenic mouse model of ALS. Rotarod test, hanging wire test and hindlimb clasping test were used to determined disease onset and assess motor performance. Immunostaining together with neuronal size measurement were used to count viable motor neurons. In addition, immunostaining procedure and ELISA kit were used to assess the inflammatory response in the spinal cord. Our results showed that Genistein administration suppressed the production of pro-inflammatory cytokines and alleviated gliosis in the spinal cord of SOD1-G93A mice. In addition, genistein administration induced autophagic processes and enhanced the viability of spinal motor neurons. As a result, genistein alleviated ALS-related symptoms and slightly prolonged the lifespan of SOD1-G93A mice. Taken together, our results indicate that genistein is neuroprotective in SOD1-G93A mice, suggesting genistein could be a promising treatment for human ALS.
相似文献